LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 211 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,429,044 | -21.0% | 100,001 | -0.0% | 0.04% | -19.2% |
Q1 2024 | $5,609,393 | -6.8% | 100,007 | +0.0% | 0.05% | -20.0% |
Q4 2023 | $6,017,000 | -10.4% | 100,000 | 0.0% | 0.06% | -17.7% |
Q3 2023 | $6,717,000 | -42.5% | 100,000 | -40.9% | 0.08% | -43.2% |
Q2 2023 | $11,687,124 | +84.4% | 169,305 | +28.8% | 0.14% | +61.6% |
Q1 2023 | $6,338,037 | -8.6% | 131,440 | -5.4% | 0.09% | -7.5% |
Q4 2022 | $6,937,233 | +29.3% | 138,967 | +5.7% | 0.09% | +24.0% |
Q3 2022 | $5,365,000 | -91.7% | 131,500 | -88.8% | 0.08% | -92.4% |
Q2 2022 | $64,408,000 | +51.3% | 1,171,051 | 0.0% | 0.99% | +43.7% |
Q1 2022 | $42,556,000 | -38.3% | 1,171,051 | -20.8% | 0.69% | -30.0% |
Q4 2021 | $68,921,000 | -7.8% | 1,478,666 | +0.0% | 0.99% | -19.2% |
Q3 2021 | $74,758,000 | +567.0% | 1,478,594 | +441.5% | 1.22% | +484.2% |
Q2 2021 | $11,208,000 | -7.7% | 273,043 | -36.7% | 0.21% | -35.1% |
Q4 2020 | $12,149,000 | +47.2% | 431,418 | +122.5% | 0.32% | -1.5% |
Q2 2020 | $8,251,000 | – | 193,857 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |